TcMedicine

Archive for the ‘Breast Cancer’ Category

Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify “sentinel nodes;”

The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Although patients with early stage, small, breast tumours have an excellent short term prognosis, more than 15 to 20 per cent

Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer says:

“Today’s announcement to review the policy on co-payments in the NHS is welcome news and should provide much needed clarity on this complex issue.

“Breakthrough Breast Cancer believes

Members of the Northeast Ohio Affiliate of Susan G. Komen for the Cure traveled to the nation’s capital June 5 to help make the case for more funding for cancer research and access to screening and treatment. During their meetings with Senator Sherrod Brown, and Representatives

The Georgia Department of Community Health has launched a $1.2 million initiative that will provide grants to groups offering breast cancer education, screening and treatment to low-income and minority women, the Atlanta Journal-Constitution reports.

The program will

The Georgia Department of Community Health has launched a $1.2 million initiative that will give grants to community groups that offer breast cancer education, screening and treatment to low-income and minority women, the Atlanta Journal-Constitution reports.

The initiative

The Coalition on Abortion/Breast Cancer notes the publication of the study, DeLellis Henderson et al. 2008, in the journal Contraception, which purports to examine the abortion-breast cancer (ABC) link. [1]

“This fraudulent study provides further strong evidence of the

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that a multicenter Phase 3 study of Lymphoseek® has been initiated in patients with either breast cancer or melanoma. The Phase 3

The Susan G. Komen National Race for the Cure drew more than 45,500 participants on Saturday in Washington, D.C., to support breast cancer research, education and treatment, the Washington Post reports. According to the Post, participants and supporters raised $4.9 million, up

CNN on Wednesday reported on triple negative breast cancer, a “rare, fast-moving cancer that has experts … stumped.” Nearly 50% of black women under age 55 who are diagnosed with breast cancer have the triple negative type, compared with 15% of all women with breast